You are here:

WHO drug-resistant TB guidelines 2022: what is new?

Published on


We fast-track accepted articles to ensure that important scientific research is shared as rapidly as possible and publish them as edited preprints, prior to publication in the IJTLD or PHA.

To subscribe to the IJTLD online or in print – either as an Institute or as an Individual – please read our Subscription Information, or email for further details.

Originally available as a preprint, this article was subsequently published in the July 2022 issue of the IJTLD. Read the article here